Amgen reports positive phase 3 results for subcutaneous TEPEZZA in thyroid eye disease
Subcutaneous delivery shows IV‑level efficacy in moderate to severe TED
Read the full article on the original site.
Read Full Article
Subcutaneous delivery shows IV‑level efficacy in moderate to severe TED
Read the full article on the original site.
Read Full Article